Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacterial Lysates for VAP Prevention
NCT05270018Unknown
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial in ventilator-associated pneumonia (VAP) (2 arms). Primary endpoint: Ventilator-associated Pneumonia incidence at 2 weeks. Status: unknown.
02
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT05270018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05270018.